v3.26.3
Sale of RPK - Schedule of Consolidated Statements of Loss and Comprehensive Loss (Details) - USD ($)
12 Months Ended
Sep. 19, 2023
Dec. 31, 2025
Dec. 31, 2024
Jun. 30, 2026
Schedule of Consolidated Statements of Loss and Comprehensive Loss [Line Items]        
Finder’s fee – transaction cost $ (500,000)      
Cash   $ 503,562 $ 3,838,650 $ 755,238
Accounts receivable   1,399,977 370,537 1,655,084
Inventory     895,715  
Property, plant and equipment, net   2,365,831 2,339,182 3,482,379
Accounts payable   (3,309,037) (2,982,499) $ (3,575,873)
Gain on sale of subsidiary   $ 198,780  
Bophelo Bio Science and Wellness (Pty) Ltd. ("Bophelo")        
Schedule of Consolidated Statements of Loss and Comprehensive Loss [Line Items]        
Cash received   2,000,000    
Finder’s fee – transaction cost   (446,250)    
Consideration received, net   1,553,750    
Cash   105,175    
Accounts receivable   158,812    
Inventory   895,715    
Prepayments   33,762    
Property, plant and equipment, net   1,769,221    
Intangible licenses   3,783,117    
Accounts payable   (2,016,744)    
Bank loans   (3,374,088)    
Net assets sold   1,354,970    
Gain on sale of subsidiary   $ 198,780